Search results for "Diabetes"


 
Results 111 - 120 of about 963 for "Diabetes".
Sort by: Relevance | Newest | Oldest

Tailoring diabetes screening by race, ethnicity may lead to earlier diagnosis

Researchers used data from the National Health and Nutrition Examination Survey to determine the body mass index and age thresholds for diabetes screening in major racial/ethnic minority populations.
https://immattersacp.org/weekly/archives/2022/05/10/1.htm
10 May 2022

Large review compares benefits, harms of drugs to treat type 2 diabetes

High-certainty evidence indicated that sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists reduce all-cause death, while finerenone probably also reduced mortality based on moderate-certainty evidence.
https://immattersacp.org/weekly/archives/2023/04/18/4.htm
18 Apr 2023

Decision support intervention for clinicians helped decrease low-value care

A tool to increase clinicians' attention to the possible harms of overtreatment among older adults, among other aims, was associated with a greater decline in prostate-specific antigen testing, unspecified urine testing, and diabetes overtreatment compared with an education-only approach.
https://immattersacp.org/weekly/archives/2024/02/06/4.htm
6 Feb 2024

Latest updates on ACP's priorities, initiatives

ACP Spotlight offers readers a look at ACP's current top priorities and initiatives, as well as highlights from our e-newsletter, ACP Internist Weekly.
https://immattersacp.org/archives/2023/10/latest-updates-on-acps-priorities-initiatives.htm
1 Oct 2023

KDIGO guideline summary provides key points for treating diabetes, chronic kidney disease

Authors from the Kidney Disease: Improving Global Outcomes (KDIGO) Work Group provided a synopsis of key recommendations on comprehensive care, glycemic monitoring and targets, lifestyle interventions, antihyperglycemic therapies, and educational and integrated care approaches.
https://immattersacp.org/weekly/archives/2023/01/10/1.htm
10 Jan 2023

ACP: Best practice for diabetes is diet, then metformin, then any second drug

New diabetes guidelines from the American College of Physicians recommend prescribing a drug when lifestyle changes don't lower hyperglycemia. Specifically, start with metformin first and then add any second oral agent.
https://immattersacp.org/weekly/archives/2012/02/07/4.htm
7 Feb 2012

Treatment pathways compared for diabetic peripheral neuropathy

Amitriptyline supplemented with pregabalin, pregabalin supplemented with amitriptyline, and duloxetine supplemented with pregabalin were similarly effective for controlling pain, a recent study found.
https://immattersacp.org/weekly/archives/2022/08/30/2.htm
30 Aug 2022

Updated warnings on fluoroquinolones, new diabetes drug

This column reviews a warning on fluoroquinolones with a risk of disabling and potentially permanent side effects, as well as approval of an injection to improve glycemic control in adults with type 2 diabetes.
https://immattersacp.org/archives/2016/10/fda.htm
1 Oct 2016

Intensive blood pressure targets didn't reduce mortality in type 2 diabetes

Intensive hypertension treatment slightly reduced the risk of stroke in type 2 diabetics, but had no effect on mortality or myocardial infarction, a new review found.
https://immattersacp.org/weekly/archives/2012/08/14/6.htm
14 Aug 2012

Nearly 50% of older U.S. adults reported taking aspirin preventively

A study of National Health and Nutrition Examination Survey data from 2011 to 2018 found that 46.7% of respondents ages 60 years and older used aspirin for primary or secondary cardiovascular disease prevention and suggested potential overuse in certain groups.
https://immattersacp.org/weekly/archives/2021/06/29/4.htm
29 Jun 2021

Result Page: Prev   7   8   9   10   11   12   13   14   15   16   Next